secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dermata Therapeutics, Inc. (DRMA)
CIK:        0001853816
Form:       8-K
Filed at:   2023-03-13T23:59:59+00:00
Accession:  0001654954-23-002711
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dermata Therapeutics files 1-for-16 reverse stock split, effective March 14, 2023
--------------------------------------------------------------------------------

- Board approved a 1-for-16 reverse split of common stock on March 8; filed with Delaware on March 13.
- Split effective 12:01 a.m. ET on March 14, 2023; Nasdaq trading begins on split-adjusted basis same day.
- No fractional shares issued; stockholders receive cash in lieu of any fractional interest.
- CUSIP number for common stock changes to 249845306.
- All outstanding options and warrants adjusted proportionally; authorized shares unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1853816/000165495423002711/0001654954-23-002711-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1853816/000165495423002711/drma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-23-002711

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer